Bio-Techne (NASDAQ:TECH) PT Raised to $81.00

Bio-Techne (NASDAQ:TECH – Get Free Report) had its target price hoisted by equities research analysts at Robert W. Baird from $73.00 to $81.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the biotechnology company’s stock. Robert W. Baird’s price objective would suggest a potential upside […]

Related Keywords

United Kingdom ,China ,Canada ,United States ,Roeland Nusse ,Robertw Baird ,Stifel Nicolaus ,Mather Group ,Scotiabank ,Royal Bank ,Family Office ,First Horizon Advisors Inc ,Harel Insurance Investments Financial Services Ltd ,Bio Techne Company Profile ,Bio Techne Corporation ,Securities Exchange Commission ,Deutsche Bank Aktiengesellschaft ,Investment Advisors Inc ,Get Free Report ,Bank Aktiengesellschaft ,Director Roeland Nusse ,Exchange Commission ,Insurance Investments ,Financial Services ,Horizon Advisors ,Techne Corporation ,Middle East ,Greater China ,Bio Techne Daily ,Bio Techne ,Nasdaq Tech ,Tech ,Medical ,87837710 ,Boost Price Target ,